United Therapeutics
UTHR
$272.69
Share price
1.08%
Change (1 day)
27.19%
Change (1 year)
Categories
United Therapeutics (UTHR) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $1.15 B
According to United Therapeutics's latest financial reports the company's total liabilities are $1.15 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
United Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $1.18 B | -5.26% |
| 2022-12-31 | $1.24 B | 3.11% |
| 2021-12-31 | $1.21 B | -0.79% |
| 2020-12-31 | $1.21 B | 7.66% |
| 2019-12-31 | $1.13 B | 91% |
| 2018-12-31 | $0.59 B | -21.78% |
| 2017-12-31 | $0.75 B | 63.66% |
| 2016-12-31 | $0.46 B | -20.75% |
| 2015-12-31 | $0.58 B | -5.52% |
| 2014-12-31 | $0.61 B | -20.99% |
| 2013-12-31 | $0.78 B | 47.3% |
| 2012-12-31 | $0.53 B | -4.83% |
| 2011-12-31 | $0.55 B | 2% |
| 2010-12-31 | $0.54 B | 37.44% |
| 2009-12-31 | $0.39 B | 24.85% |
| 2008-12-31 | $0.31 B | 9.6% |
| 2007-12-31 | $0.29 B | 6.93% |
| 2006-12-31 | $0.27 B | 1569.82% |
| 2005-12-31 | $16.31 M | 5.08% |
| 2004-12-31 | $15.52 M | 32.25% |
| 2003-12-31 | $11.73 M | -9.07% |
| 2002-12-31 | $12.9 M | -17.9% |
| 2001-12-31 | $15.72 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 11,758.35% | 🇺🇸 USA |
 Eli Lilly LLY | $51.04 B | 4,311.55% | 🇺🇸 USA |
 Baxter BAX | $19.55 B | 1,589.83% | 🇺🇸 USA |
 Gilead Sciences GILD | $39.37 B | 3,302.99% | 🇺🇸 USA |
 Cardinal Health CAH | $49.14 B | 4,147.00% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $57.22 B | 4,845.48% | 🇬🇧 UK |
 Cytokinetics
CYTK | $1.21 B | 4.63% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $35.35 B | 2,955.31% | 🇮🇱 Israel |